Sign up
Log in
12 Health Care Stocks Moving In Thursday's Intraday Session
Share
Listen to the news

Gainers

  • Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 81.6% to $0.62 during Thursday's regular session. The market value of their outstanding shares is at $2.0 million. As per the news, the Q4 earnings report came out 4 days ago.
  • Sharps Technology (NASDAQ:STSS) shares rose 66.42% to $0.02.
  • Conduit Pharmaceuticals (NASDAQ:CDT) stock rose 50.58% to $0.93. The market value of their outstanding shares is at $8.9 million.
  • Bio-Rad Laboratories (NYSE:BIO) stock increased by 38.04% to $311.01. The market value of their outstanding shares is at $8.7 billion.
  • Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 33.99% to $1.46. The market value of their outstanding shares is at $3.9 million.
  • Bionano Genomics (NASDAQ:BNGO) stock increased by 27.67% to $3.93. The market value of their outstanding shares is at $10.7 million.

Losers

  • Venus Concept (NASDAQ:VERO) shares fell 52.8% to $4.22 during Thursday's regular session. The company's market cap stands at $2.7 million.
  • Lucid Diagnostics (NASDAQ:LUCD) stock declined by 24.78% to $1.24. The company's market cap stands at $112.6 million.
  • Brainstorm Cell (NASDAQ:BCLI) shares declined by 21.76% to $0.87. The company's market cap stands at $4.9 million.
  • Novavax (NASDAQ:NVAX) shares decreased by 21.2% to $5.32. The market value of their outstanding shares is at $855.5 million.
  • DIH Holding US (NASDAQ:DHAI) stock declined by 21.12% to $0.13. The market value of their outstanding shares is at $6.0 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) shares declined by 19.59% to $4.08. The company's market cap stands at $2.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.